abs192.txt	bcg	has	been	used	as	intravesical	immunotherapy	for	the	treatment	of	bladdercarcinoma		however	this	is	not	harmless	and	may	lead	to	complications	with	a	reported	incidence	systemic	infection	ranging	from	3%	7%	wereport	case	culture-proven	mycobacterium	bovis	(bcg)	vertebral	osteomyelitisin	72-year-old	patient	bladder	carcinoma	who	was	treated	intravesicalmitomycin	c	but	did	receive	cultures	biopsy	recovered	isolateresembling	tuberculosis	biochemically	resistant	topyrazinamide	(pza)	originally	started	on	four-drugantituberculous	regimen	isoniazid	rifampin	ethambutol	pza	aftergenotypic	analysis	identified	organism	m	waschanged	12	months	responded	well	tothis	unique	received	only	implying	possibility	transmission	fromcontaminated	equipment
